CEO Salary & Executive Compensation
Pfizer PFE
CEO: Albert Bourla · Pharmaceuticals · 88,000 employees
Albert Bourla, CEO of Pfizer (PFE), earned $12.0M in total compensation in 2025. Pfizer receives a Pay-for-Performance grade of C (61/100), with a CEO-to-worker pay ratio of 120:1 and a say-on-pay shareholder approval of 86.8%. The company's 3-year total shareholder return is -4.2%.
How Pfizer CEO Pay Compares
Albert Bourla's $12.0M total compensation is 0% below the Pharmaceuticals industry median of $12.0M. The 120:1 CEO-to-worker pay ratio is 4% lower than the industry average of 125:1.
Total compensation for Albert Bourla at Pfizer (PFE) was $12.0M. Mid-cap public-company CEO packages tend to track this pattern — equity-heavy, multi-year vesting, performance-tied.
The CEO-to-median-worker pay ratio runs 120x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Three-year performance has been roughly flat — TSR of -4.2% alongside 3.4% revenue growth. Flat performance over a multi-year window is where pay-versus-performance debates get the most heated: large compensation packages without commensurate shareholder returns are the modal complaint at annual meetings.
Shareholders supported the compensation package at 87% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. Pfizer operates in Pharmaceuticals with 88,000 employees and $58.5B in annual revenue, and currently carries a market capitalization of $160.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for Pfizer (PFE).
Compensation Breakdown
Albert Bourla's $12.0M total compensation package for fiscal year 2025 includes $1.2M in base salary, $6.0M in stock awards, $1.4M in option awards, and $1.8M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2024 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2023 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2022 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Albert Bourla, CEO of Pfizer (PFE), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Albert Bourla, CEO of Pfizer (PFE), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Pfizer has a Pay-for-Performance Score of C (61/100). The company's 3-year total shareholder return is -4.2%, and the say-on-pay shareholder vote passed with 86.8% approval.
The CEO-to-median-worker pay ratio at Pfizer is 120:1. The median worker at Pfizer earns $100K per year, while CEO Albert Bourla earns $12.0M in total compensation.
Pfizer employs approximately 88,000 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $58.5B in annual revenue.